Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 4, 2007, Pages 719-724

  Szczesny, Tomasz Jaroslaw ^a,c   Slotwinski, Robert ^b,d   Stankiewicz, Aleksander ^c   Szczygiel, Bruno ^d   Zaleska, Marzanna ^b   Kopacz, Maria ^d  

^a Regional Lung Diseases Hospital   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c City Hospital   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Complications; IL 1ra; IL 6; Lung cancer; Surgery

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; AIR EMBOLISM; ARTICLE; ATELECTASIS; BRONCHUS FISTULA; BRONCHUS STENOSIS; CANCER PATIENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LOBECTOMY; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PLEURA EMPYEMA; PLEURA FLUID; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SPUTUM ANALYSIS; STROKE; SURGICAL MORTALITY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SPUTUM;

EID: 33947118268     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.01.027     Document Type: Article

References (19)

1. Brunelli A., Sabbatini A., Xiume F., Borri A., Salati M., Marasco R.D., and Fianchini A. Inability to perform maximal stair climbing test before lung resection: a propensity score analysis on early outcome. Eur J Cardiothorac Surg 27 (2005) 367-372
2. Motta G., and Ratto G.B. Complications of surgery in the treatment of lung cancer. Their relationship with the extent of resection and preoperative respiratory function tests. Acta Chir Belg 89 (1989) 161-165
3. Nagasaki F., Flehinger B.J., and Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest 82 (1982) 25-29
4. Mokart D., Merlin M., Sannini A., Brun J.P., Delpero J.R., Houvenaeghel G., Moutardier V., and Blache J.L. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94 6 (2005) 767-773
5. Yamada T., Hisanaga M., Nakajima Y., Kanehiro H., Watanabe A., Ohyama T., Nishio K., Sho M., Nagao M., Harada A., Matsushima K., and Nakano H. Serum interleukin-6, interleukin-8, hepatocyte growth factor, and nitric oxide changes during thoracic surgery. World J Surg 22 (1998) 783-790
6. Slotwinski R., Olszewski W.L., Chaber A., Słodkowski M., Zaleska M., and Krasnode{ogonek}bski I.W. The soluble tumor necrosis factor receptor I (sTNFR I) is an early predictor of local infective complications after colorectal surgery. J Clin Immunol 22 5 (2002) 289-296
7. Grzelak I., Olszewski W.L., Zaleska M., Durlik M., Lagiewska B., Muszynski M., and Rowinski W. Blood cytokine levels rise even after minor surgical trauma. J Clin Immunol 16 3 (1996) 159-164
8. Sugi K., Kaneda Y., and Esato K. Video-assisted thoracoscopic lobectomy reduces cytokine production more than conventional open lobectomy. Jpn J Thorac Cardiovasc Surg 48 3 (2000) 161-165
9. Ng C.S., Lee T.W., Wan S., Wan I.Y., Sihoe A.D., Arifi A.A., and Yim A.P. Thoracotomy is associated with significantly more profound suppression in lymphocytes and natural killer cells than video-assisted thoracic surgery following major lung resections for cancer. J Invest Surg 18 2 (2005) 81-88
10. Slotwinski R., Olszewski W.L., Lech G., Chaber A., Slodkowski M., Zaleska M., and Krasnodebski I.W. The reoperation for infective complications after major surgery of pancreas does not evoke additional cytokine response. Cent Eur J Immunol 31 1-2 (2006) 31-35
11. Abe T., Oka M., Tangoku A., Hayashi H., Yamamoto K., Yahara N., Morita K., Tabata T., and Ohmoto Y. Interleukin-6 production in lung tissue after transthoracic esophagectomy. J Am Coll Surg 192 (2001) 322-329
12. Takeuchi E., Ito M., Mori M., Yamaguchi T., Nakagawa M., Yokota S., Nishikawa H., Sakuma-Mochizuki J., Hayashi S., and Ogura T. Lung cancer producing interleukin-6. Intern Med 35 3 (1996) 212-214
13. Freeman B.D., and Buchman T.G. Interleukin-1 receptor antagonist as therapy for inflammatory disorders. Expert Opin Biol Ther 1 (2001) 301-308
14. Whiteside T.L. Cytokine assays. Biotechniques 33 Suppl. (2002) 4-15
15. Pala P., Hussell T., and Openshaw P.J. Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243 (2000) 107-124
16. Atwell D.M., Grichnik K.P., Newman M.F., Reves J.G., and McBride W.T. Balance of proinflammatory and antiinflammatory cytokines at thoracic cancer operation. Ann Thorac Surg 66 4 (1998) 1145-1150
17. Yim A.P., Wan S., Lee T.W., and Arifi A.A. VATS lobectomy reduces cytokine responses compared with conventional surgery. Ann Thorac Surg 70 1 (2000) 243-247
18. Craig S.R., Leaver H.A., Yap P.L., Pugh G.C., and Walker W.S. Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg 20 3 (2001) 455-463
19. Sato N., Koeda K., Kimura Y., Ikeda K., Ogawa M., Saito K., and Endo S. Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. Eur Surg Res 33 (2001) 279-284